Role of ultrasound-guided optical tomography in evaluation of breast cancer during neoadjuvant chemotherapy
10.3760/cma.j.issn.1004-4477.2014.12.016
- VernacularTitle:超声光散射技术对于乳腺癌新辅助化疗临床疗效的评价作用
- Author:
Yan DONG
;
Cai CHANG
;
Jinwei QIANG
;
Shichong ZHOU
;
Jian LE
- Publication Type:Journal Article
- Keywords:
Ultrasonography;
Breast neoplasms;
Chemotherapy,adjuvant;
US-diffuse optical tomography
- From:
Chinese Journal of Ultrasonography
2014;23(12):1065-1069
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the value of ultrasound-diffuse optical tomography(US-DOT) in evaluation of the response to neoadjuvant chemotherapy (NCT) in patients with breast cancer.Methods Fifty women with breast cancer confirmed by biopsy-pathology scheduled to undergo NCT were enrolled.US-DOT was performed and the total hemoglobin concentration(HbT) prior to and at the end of NCT.According to the response to treatment in solid tumors,patients were divided into complete response(CR) group,partial response (PR) group,stable disease (SD) group and progressive disease (PD) group.The analysis of variance compared the differences of HbT before and after NCT in each group; Pearson correlation analyzed the relationship between the relative HbT variation and the tumor size changes;Mixedeffects model analyzed the relationship between HbT and tumor size.Results After NCT,CR group had 8 cases,PR group 30 cases,SD group 12 cases and no PD cases.Before and after NCT,the mean relative variations of HbT before and after NCT were-0.525 ± 0.222,-0.328 ± 0.180 and-0.173 ± 0.167 in CR,PR and SD groups,respectively.The differences of HbT before and after NCT were statistically significant in each group (P ＜0.05).There was significant difference among tumor diameter and HbT in CR group and PR group (P ＜0.001);while in the SD group,there was no difference among tumor diameter and HbT (P ＞ 0.05).The change of HbT after NCT showed positive correlation with the change in tumor size (r =0.6).Mixed-effects model also showed that HbT change was associated with tumor size.Conclusions USDOT marker HbT is closely related to tumor size of breast cancer before and after NCT and may be applied to evaluate the response of breast cancer to NCT.
